Bank of New York Mellon Corp - CINCOR PHARMA INC ownership

Back to all holdings Add to watchlist

CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 106 filers reported holding CINCOR PHARMA INC in Q4 2022. The put-call ratio across all filers is 2.63 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CINCOR PHARMA INC
ValueSharesWeighting
Q4 2022$929,394
-61.1%
75,622
+3.8%
0.00%
-100.0%
Q3 2022$2,391,000
+265.0%
72,863
+109.4%
0.00%–
Q2 2022$655,000
+15.9%
34,796
+8.0%
0.00%–
Q1 2022$565,000–32,210–0.00%–
 Download
Other shareholders
CINCOR PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CINCOR PHARMA INC shareholders